The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis dependent chronic kidney disease patients: An updated systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Roxadustat (ROX) is a new medication for anemia as a complication of chronic kidney disease (CKD). Our meta-analysis aims to evaluate the efficacy and safety of ROX, especially on the cardiovascular risks, for anemia in NDD-CKD patients. METHODS: Electronic databases were searched system...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelazeem, Basel, Shehata, Joseph, Abbas, Kirellos Said, El-Shahat, Nahla Ahmed, Malik, Bilal, Savarapu, Pramod, Eltobgy, Mostafa, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974992/
https://www.ncbi.nlm.nih.gov/pubmed/35363823
http://dx.doi.org/10.1371/journal.pone.0266243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974992/
https://www.ncbi.nlm.nih.gov/pubmed/35363823
http://dx.doi.org/10.1371/journal.pone.0266243

Ejemplares similares